(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.
Hcw Biologics's earnings in 2026 is -$22,206,013.On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$13,805,752, with the lowest HCWB earnings forecast at -$13,264,350, and the highest HCWB earnings forecast at -$14,211,804. On average, 3 Wall Street analysts forecast HCWB's earnings for 2027 to be -$7,495,338, with the lowest HCWB earnings forecast at -$7,201,404, and the highest HCWB earnings forecast at -$7,715,790.
In 2028, HCWB is forecast to generate -$6,172,632 in earnings, with the lowest earnings forecast at -$5,930,568 and the highest earnings forecast at -$6,354,180.